Depression and fatigue are conditions responsible for heavy global societal burden,
especially in patients already suffering from chronic diseases. These symptoms have been …

Comorbidities in patients with multiple sclerosis (MS) has become an area of increasing
interest in the recent years. A comorbidity is defined as any additional disease that coexists …

There is growing evidence of a relationship between inflammation and psychiatric illness. In
particular, the cytokine Interleukin-6 (IL-6) has been linked to stress-related disorders such …

Most efforts aimed at understanding the notable heterogeneity of outcomes in multiple
sclerosis (MS) have focused on disease-specific factors, such as symptoms at initial …

Objective Early diagnosis and treatment initiation significantly influence long‐term disability
outcome in multiple sclerosis (MS). We aimed at identifying prodromal symptoms of MS in …

Purpose Multiple sclerosis (MS) is a chronic condition linked to a wide range of
psychological difficulties. While traditional cognitive behavioural therapy has been studied …

Objectives To investigate the longitudinal relationships between social support and
subsequent mental health outcomes in individuals with multiple sclerosis (MS), and to …

Major depressive disorder (MDD) is a common condition that afflicts the general population
across a broad spectrum of ages and social backgrounds. MDD has been identified by the …

Aims. After the diagnosis of immune-mediated inflammatory diseases (IMID) such as
inflammatory bowel disease (IBD), multiple sclerosis (MS) and rheumatoid arthritis (RA), the …

Objective Depression is common in multiple sclerosis (MS), but its impact on disability
worsening has not yet been determined. We explored the risk of disability worsening …